2-237368736-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004369.4(COL6A3):​c.4727G>A​(p.Arg1576Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0154 in 1,614,182 control chromosomes in the GnomAD database, including 244 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1576W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.010 ( 18 hom., cov: 32)
Exomes 𝑓: 0.016 ( 226 hom. )

Consequence

COL6A3
NM_004369.4 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.15

Publications

17 publications found
Variant links:
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]
COL6A3 Gene-Disease associations (from GenCC):
  • Bethlem myopathy 1A
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1C
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • dystonia 27
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AR, AD, SD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046691597).
BP6
Variant 2-237368736-C-T is Benign according to our data. Variant chr2-237368736-C-T is described in ClinVar as Benign. ClinVar VariationId is 94938.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0105 (1593/152288) while in subpopulation NFE AF = 0.0172 (1171/68012). AF 95% confidence interval is 0.0164. There are 18 homozygotes in GnomAd4. There are 757 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 18 AD,AR,SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A3NM_004369.4 linkc.4727G>A p.Arg1576Gln missense_variant Exon 10 of 44 ENST00000295550.9 NP_004360.2 P12111-1D9ZGF2Q8N4Z1Q63HQ4
COL6A3NM_057167.4 linkc.4109G>A p.Arg1370Gln missense_variant Exon 9 of 43 NP_476508.2 P12111-2Q8N4Z1Q63HQ4
COL6A3NM_057166.5 linkc.2906G>A p.Arg969Gln missense_variant Exon 7 of 41 NP_476507.3 P12111-4B7ZW00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A3ENST00000295550.9 linkc.4727G>A p.Arg1576Gln missense_variant Exon 10 of 44 1 NM_004369.4 ENSP00000295550.4 P12111-1
COL6A3ENST00000472056.5 linkc.2906G>A p.Arg969Gln missense_variant Exon 7 of 41 1 ENSP00000418285.1 P12111-4
COL6A3ENST00000353578.9 linkc.4109G>A p.Arg1370Gln missense_variant Exon 9 of 43 5 ENSP00000315873.4 P12111-2
COL6A3ENST00000684597.1 linkc.116-60G>A intron_variant Intron 1 of 2 ENSP00000508021.1 A0A804HKQ0

Frequencies

GnomAD3 genomes
AF:
0.0105
AC:
1594
AN:
152170
Hom.:
18
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00299
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.0119
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.00433
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0172
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00994
AC:
2501
AN:
251486
AF XY:
0.0103
show subpopulations
Gnomad AFR exome
AF:
0.00246
Gnomad AMR exome
AF:
0.00529
Gnomad ASJ exome
AF:
0.00119
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00568
Gnomad NFE exome
AF:
0.0170
Gnomad OTH exome
AF:
0.00896
GnomAD4 exome
AF:
0.0159
AC:
23304
AN:
1461894
Hom.:
226
Cov.:
34
AF XY:
0.0156
AC XY:
11324
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.00245
AC:
82
AN:
33480
American (AMR)
AF:
0.00537
AC:
240
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00134
AC:
35
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00552
AC:
476
AN:
86258
European-Finnish (FIN)
AF:
0.00569
AC:
304
AN:
53420
Middle Eastern (MID)
AF:
0.00728
AC:
42
AN:
5768
European-Non Finnish (NFE)
AF:
0.0192
AC:
21398
AN:
1112012
Other (OTH)
AF:
0.0120
AC:
727
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
1511
3022
4534
6045
7556
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0105
AC:
1593
AN:
152288
Hom.:
18
Cov.:
32
AF XY:
0.0102
AC XY:
757
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00298
AC:
124
AN:
41558
American (AMR)
AF:
0.0119
AC:
182
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5172
South Asian (SAS)
AF:
0.00373
AC:
18
AN:
4824
European-Finnish (FIN)
AF:
0.00433
AC:
46
AN:
10622
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0172
AC:
1171
AN:
68012
Other (OTH)
AF:
0.00615
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
85
171
256
342
427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0147
Hom.:
34
Bravo
AF:
0.0106
TwinsUK
AF:
0.0191
AC:
71
ALSPAC
AF:
0.0210
AC:
81
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.0156
AC:
134
ExAC
AF:
0.0103
AC:
1246
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.0154
EpiControl
AF:
0.0154

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Nov 05, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 29, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Oct 29, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Collagen 6-related myopathy Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Bethlem myopathy 1A Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.21
.;T;.;T;.
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.42
FATHMM_MKL
Benign
0.18
N
LIST_S2
Uncertain
0.90
D;D;D;D;.
MetaRNN
Benign
0.0047
T;T;T;T;T
MetaSVM
Benign
-0.67
T
MutationAssessor
Benign
0.90
.;L;.;.;.
PhyloP100
1.1
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.8
N;N;N;.;N
REVEL
Benign
0.28
Sift
Benign
0.073
T;T;T;.;T
Sift4G
Uncertain
0.024
D;D;D;D;D
Polyphen
1.0
D;P;.;.;D
Vest4
0.23
MPC
0.38
ClinPred
0.014
T
GERP RS
4.5
Varity_R
0.21
gMVP
0.72
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61729839; hg19: chr2-238277379; COSMIC: COSV99799739; COSMIC: COSV99799739; API